News About: Pharm. Industry
Fosamax Plus patent doesn't belong to patent scope of Maxmarvil, Intellectual Property Tribunal says
The Korea Intellectual Property Tribunal rejected Yuyu Pharm's request to confirm whether MSD Korea's Fosamax Plus (70 mg alendronate/5,600 IU vitamin D3) is not in the patent scope of Yuyu's Maxmarvil (Korean Patent ...
Drug makers face tough times
Local pharmaceutical firms are facing tough times ahead as the Korean won's rise against the U.S. dollar, stemming from growing worries over economic woes of the world's largest economy, has prompted the government to...
Emin Turan named new president of Sanofi PasteurSanofi Pasteur Korea has appointed Emin Turan, the vaccines business of Sanofi Aventis Group, as president effective October 25.
The company is providing superior, innovative...
|
Daewoong unveils stomatitis medicationDaewoong has unveiled its supplemental agent (trade name: Impactamine, 12 tablets per pack) for relieving stomatitis, inflammation of the oral mucosa, from this month.
Accord...
|
Listed pharmaceutical firms' sales up but profit down
The public notices of 25 pharmaceutical firms whose fiscal year corresponding with the calendar year disclosed that their sales were up but their profits down in the nine months of this year.
The 25 firms mark...
KFDA warns pediatric risk on 119 cold medicines for under age of 6
The Korea Food and Drug Administration will issue a caution to pharmacists about prescribing OTC cough and cold drugs for children less than six years of age, following the recent reports of a US Food and Drug Adminis...
Janssen Korea to take legal actions over Ultracet
Janssen Korea has pledged to take legal action against the nullification trial of Ultracet, a painkiller for the relief of moderate to severe pain, which has been raised by several Korean drug makers including Hanmi P...
Pharmcoeconomic majors gaining popularity
A number of domestic pharmaceutical firms, including foreign-invested pharmaceutical manufacturers, are struggling to hire university graduates who majored in pharmacoeconomics, in bid to cope with the government's ne...
Korea's two credit agencies award 'A+' rating to Daewoong Pharm
Korea Ratings and Korea Information Service, Korea's top credit rating agencies, said they have raised Daewoong Pharm's credit rating from A to A+.
The rating reflects Daewoong's strong market position and good pr...
Kuhnil to introduce anticancer drug from Taiwan
Kuhnil Phar has signed an exclusive agreement with Taiwan-headquartered TTY BioPharm to distribute an anticancer medicine, Lipo-Dox (pegylated liposomal doxorubicin), in Korea.
Doxorubicin is a chemotherapy drug. I...
